Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation. - Wikidata - wikimedia - TriplyDB

Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.

Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.

http://www.wikidata.org/entity/Q33670408

about

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms Nanoparticle ligand presentation for targeting solid tumors Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5 Somatostatin Depresses the Excitability of Subicular Bursting Cells: Roles of Inward Rectifier K+ Channels, KCNQ channels and Epac.A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation.Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus.Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists.Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.Differentiation of opioid drug effects by hierarchical multi-site phosphorylation Illuminating somatostatin analog action at neuroendocrine tumor receptors Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C Pasireotide for the treatment of Cushing's disease.Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2--clinical implications Determination of GPCR Phosphorylation Status: Establishing a Phosphorylation Barcode.Rapid dephosphorylation of G protein-coupled receptors by protein phosphatase 1β is required for termination of β-arrestin-dependent signaling.Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line.Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.Structural determinants of agonist-selective signaling at the sst(2A) somatostatin receptor.Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking.Differential regulation of somatostatin receptor dephosphorylation by β-arrestin1 and β-arrestin2.Reassessment of sst3 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-5.Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature

P2860

Q26796357-B5B67B19-AD19-4A97-A428-FDEA3762CC13 Q26862544-D2BB9204-97DE-4521-82B0-A1D584DB1D58 Q27009522-206EA524-0D84-43EB-930A-B5AD2507C4B9 Q27021274-3D26DC02-C4CA-4E20-B6B7-87BADBBE6DDA Q30101028-EE95F6F3-C45F-408B-ADD4-C48CA9A822FE Q34321414-13ACA9FB-3253-4F65-8BE9-3D556D3BF29D Q34755795-9743CBD0-3BFD-4DE9-8AA2-967460CB2C43 Q35001258-6B04F1E0-8310-4CEE-B017-5D7DB33D6452 Q35106253-AB2093F2-E299-4509-88EB-435E32253462 Q36642376-6FE3DC1C-838B-431C-8885-2589C7BE4661 Q37443562-4E96BCA5-B392-4D1F-A843-E297F9431258 Q37635282-25C01E92-AE85-4852-A151-B84B65200008 Q37763714-61559826-3447-4364-8172-7D12544E1CB4 Q37772579-2AF32E6E-1575-44B2-9236-D25E9A608623 Q38581932-5C9949D9-A851-4F6E-8EB0-C295DD9E0785 Q38675387-949112D0-93DC-4D04-A95D-9C5B783D9958 Q38758506-DC71D3E2-D830-4213-A131-668A33B2DC3C Q38815549-636D6F23-0FE3-43DA-868C-4D7A67E92C97 Q41548629-842767D6-B066-4171-BCA6-59F6C6DF296F Q42000724-BD610841-40E3-42D3-8CF5-8C982852C495 Q42289652-6825F04F-66DB-4EB7-941F-DCB4D4EF167E Q42289699-B070DCB6-25A9-46C6-AD1F-84793D1C2AB7 Q42289796-2A7104B9-A105-4A03-86D2-83092A5D43F8 Q45349770-A7B7683B-4343-449B-84CE-4EB84F03D84F Q48616839-4436027D-F1AA-42D1-B2AF-3ED1907860A2 Q51170240-2F3EE653-D040-44F3-BAF4-1126904C7713 Q57144951-0F66BB01-07DB-4598-97AA-9E4EBAB833E5

P2860

Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.

http://www.wikidata.org/entity/Q33670408

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pasireotide and octreotide sti ...... atin receptor phosphorylation.

@ast

Pasireotide and octreotide sti ...... atin receptor phosphorylation.

@en

type

label

Pasireotide and octreotide sti ...... atin receptor phosphorylation.

@ast

Pasireotide and octreotide sti ...... atin receptor phosphorylation.

@en

prefLabel

Pasireotide and octreotide sti ...... atin receptor phosphorylation.

@ast

Pasireotide and octreotide sti ...... atin receptor phosphorylation.

@en

P1433

Q33670408-3703F34A-CEBC-4DB2-8076-9A5CB1151AE8

P1476

Q33670408-75538CDC-818B-4B75-9E0C-450C8501D302

P2093

Q33670408-0ACF29C1-B633-4201-9418-A83C8660FEA1

Q33670408-40B55979-9229-4AD7-AA4A-8D8B1E11E438

Q33670408-79FD4AE5-ABEC-4DA7-867B-7A9FA1E26AF4

Q33670408-7CF91EC6-1219-4C39-9D2F-3A3D0D107809

Q33670408-9188C3A6-576C-4896-913F-55D058E4236F

Q33670408-B82C113D-319A-4FDD-90DA-ACC953C148BB

Q33670408-E3A5AAB7-128C-44ED-9E16-1A8F2DEECD1B

Q33670408-EEB99134-6652-4B3C-A387-B69B25B0C3A5

P2860

Q33670408-011C88AA-FBD8-4FA7-80F8-95D678BF4F7B

Q33670408-067A6212-5D32-4250-9E62-72AB2732B437

Q33670408-0726EC38-4DA6-4134-A118-A13EDF84B3A8

Q33670408-0F0ADFF0-80E1-4753-94AC-E699F300532A

Q33670408-0F8B6E60-4F8E-4B7F-80C7-282AC054B5C2

Q33670408-15DA2CBE-9C5E-4452-8CDA-270706C223E0

Q33670408-19F5104C-1F7E-4E59-81DC-1DCC3FF3A0BB

Q33670408-2829F9A0-62E2-4455-ACB0-A69C04A0B0DB

Q33670408-2FB098F2-1BC4-4841-8EF7-351492578D9C

Q33670408-3139E746-BCD7-4D91-9440-B253A197A696

P304

Q33670408-D9C84589-13E6-4EBC-A89D-E0142F4C8756

P31

Q33670408-FE1EF387-3A79-44B4-B0AD-55660CFB6D37

P356

Q33670408-FAB4062A-A3A9-4518-AE83-02AE3087CA2C

P433

Q33670408-B3F28F69-2D67-409E-A8DA-95D796B758F6

P478

Q33670408-76DF86C0-8CCC-47AF-A624-A419E152202A

P577

Q33670408-68C47C39-EC73-49CA-82B4-330081C60B64

P698

Q33670408-940EC5C6-A5D4-4CB9-BB34-5FCC93C968CD

P921

Q33670408-9600542E-63D3-4F4E-8F90-6B7D5133EF82

P932

Q33670408-AC7CE126-B722-420E-B8B6-64D374FDD13C

P356

P1433

Molecular Endocrinology

P1476

Pasireotide and octreotide sti ...... atin receptor phosphorylation.

@en

P2093

Amelie Lupp

http://www.w3.org/2001/XMLSchema#string

Diana Lehmann

http://www.w3.org/2001/XMLSchema#string

Florian Pöll

http://www.w3.org/2001/XMLSchema#string

Mihaela Ginj

http://www.w3.org/2001/XMLSchema#string

Ralf Stumm

http://www.w3.org/2001/XMLSchema#string

Stefan Jacobs

http://www.w3.org/2001/XMLSchema#string

Stefan Schulz

http://www.w3.org/2001/XMLSchema#string

Susann Illing

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*

Transduction of receptor signals by beta-arrestins

Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment

Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).

Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.

Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.

Opportunities in somatostatin research: biological, chemical and therapeutic aspects.

The role of somatostatin analogs in Cushing's disease.

Treatment of acromegaly: future.

P304

436-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/ME.2009-0315

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20051480

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

5428126

http://www.w3.org/2001/XMLSchema#string